Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Unknown 2

Sponsor Class

OTHER 1976INDUSTRY 594NIH 304NETWORK 94FED 20OTHER_GOV 17UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 44Breast 32Thoracic 13Head & Neck 12Lymphoid 8CNS 4Gynecologic 3Sarcoma 2Genitourinary 2Other solid neoplasm 1Other neoplasm 1NET 1Endocrine 1

Conditions

Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1

Interventions

pyrotinib 1Trastuzumab 1Sorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Genitourinary × Clear all
NCT05318339 2022-04-08

A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT01041482 2010-01-06

AGuo

ChineseAMS

Phase 2 Unknown
140 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡